The Antiandrogen and Hormonal Treatment of Sex Offenders

  • J. M. W. Bradford
Part of the Applied Clinical Psychology book series (NSSB)


The treatment of sexual offenders using hormonal agents and antiandrogens is an increasingly important approach to a difficult clinical problem. As the public becomes more focused on the problem of sexual offenders and particularly child molesters, the demand for longer terms of incarceration as a solution to the problem has escalated, whereas the rehabilitation and treatment component has been deemphasized. It is in this climate that the need for effective treatment approaches supported by outcome studies is essential. At least part of the problem is that the term sexual offender can mean anything from a violent sadistic predatory rapist to an inhibited exhibitionist.


Sexual Behavior Androgen Receptor Sexual Offender Psychosomatic Medicine Ethinyl Estradiol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abel, G. G., Barlow, D. H., Blanchard, E., and Guild, D. (1977). The components of rapists’ sexual arousal. Archives of General Psychiatry, 43, 895–903.CrossRefGoogle Scholar
  2. Abel, G. G., Blanchard, E., Becker, J., and Djenderedjian, A. (1978). Differentiating sexual aggressives with penile measures. Criminal Justice and Behavior, 5, 315–332.CrossRefGoogle Scholar
  3. Bancroft, J., Tennent, G., Loucas, K., and Cass, J. (1974). The control of deviant sexual behaviour by drugs: I. Behavioural changes following oestrogens and antiandrogens. British Journal of Psychiatry, 125, 310–315.PubMedCrossRefGoogle Scholar
  4. Barbaree, H. E., Marshall, W. L., and Lanthier, R. D. (1979). Deviant sexual arousal in rapists. Behaviour Research and Therapy, 17, 215–222.PubMedCrossRefGoogle Scholar
  5. Berlin, F. S., and Meinecke, C. F. (1981). Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities and preliminary findings. American Journal of Psychiatry, 138, 601–607.PubMedGoogle Scholar
  6. Blumer, D., and Migeon, C. (1975). Hormone and hormonal agents in the treatment of aggression. Journal of Nervous and Mental Disorders, 160, 127–137.CrossRefGoogle Scholar
  7. Bradford, J. M. W., (1983). Research in sex offenders. In R. L. Sadoff (Ed.), The psychiatric clinics of North America (pp. 715–733 ). Philadelphia: W. B. Saunders.Google Scholar
  8. Bradford, J. M. W. (1985). Organic treatments for the male sexual offender. Behaviour Sciences and the Law, 3, 355–375.Google Scholar
  9. Bradford, J. M. W., and Bourget, D. (1987). Sexually aggressive men. Psychiatric Journal of the University of Ottawa XII (3), 169–175.Google Scholar
  10. Bradford, J. M. W., and McLean, D. (1984). Sexual offenders, violence and testosterone: A clinical study. Canadian Journal of Psychiatry, 29, 335–343.Google Scholar
  11. Bradford, J. M. W., and Pawlak, A. (1987a). Sadistic homosexual pedophilia: Treatment with cyproterone acetate. A single case study. Canadian Journal of Psychiatry, 32, 22–31.Google Scholar
  12. Bradford, J. M. W., and Pawlak, A. (1987b). The effects of cyproterone acetate on the sexual arousal patterns of pedophiles. Manuscript submitted for publication.Google Scholar
  13. Bradford, J. M. W., and Pawlak, A. (in press). Double-blind placebo crossover study of cyproterone acetate in the treatment of sexual deviation-Phase 1. Canadian Journal of Psychiatry. Google Scholar
  14. Bremer, J. (1959). Asexualization-A followup study of 244 cases. New York: MacMillanGoogle Scholar
  15. Brown, W. A., and Davis, G. H. (1957). Serum testosterone and irritability in man. Psychosomatic Medicine, 37, 87.Google Scholar
  16. Cooper, A. J. (1981). A placebo controlled study of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22, 458–464.PubMedCrossRefGoogle Scholar
  17. Cooper, A. J., Ismail, A. A., Phanjoo, A. L., and Love, D. L. (1972). Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. British Journal of Psychiatry, 120, 59–63.PubMedCrossRefGoogle Scholar
  18. Cordoba, O. A., and Chapel, J. L. (1983). Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a paedophiliac sex offender. American Journal of Psychiatry, 140, 1036–1039.PubMedGoogle Scholar
  19. Cremonocini, C., Viginati, E., and Libroia, A. (1976). Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinyloestradiol. Acta European Fertility, 7, 299–314.Google Scholar
  20. Davidson, J. M., Smith, E. R., and Damassa, D. A. (1977). Comparative analysis of the roles of androgen in the feedback mechanisms and sexual behavior. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 137–149 ) New York: Raven Press.Google Scholar
  21. Davidson, P. R., and Malcolm, P. B. (1985). The reliability of the rape index: a rapist sample. Behavioural Assessment, 7, 283–292.Google Scholar
  22. Davies, T. D. (1974). Cyproterone acetate for male hypersexuality. Journal of International Medical Research, 2, 159–163.PubMedGoogle Scholar
  23. Dourer, G. (1977). Sex-hormone-dependent brain differentiation and reproduction. In J. Money and H. Musaph (Eds.). Handbook of sexology II. Genetics, hormones and behaviour (pp. 227–245 ). New York: Elsevier.Google Scholar
  24. Ehrenkranz, J., Bliss, E., and Sheard, M. H. (1974). Plasma testosterone: Correlation with aggressive behavior and social dominance in man. Psychosomatic Medicine, 36, 469–475.PubMedGoogle Scholar
  25. Field, L. H. (1973). Benperidol in the treatment of sex offenders. Medicine Science and the Law, 13, 195–196.Google Scholar
  26. Foote, R. M. (1944). Diethystilbestrol in the management of psychopathological states in males. Journal of Nervous and Mental Disease, 99, 928–935.CrossRefGoogle Scholar
  27. Gagne, P. (1981). Treatment of sex offenders with medroxyprogesterone acetate. American Journal of Psychiatry, 138, 644–646.PubMedGoogle Scholar
  28. Golia, F. L., and Hodge, S. R. (1949). Hormone treatment of sexual offenders. Lancet, 1, 1006–1007.CrossRefGoogle Scholar
  29. Groth, A. N. (1979). Men who rape: The psychology of the offender, New York: Plenum.Google Scholar
  30. Groth, A. N., Burgess, A. W., and Holmstrom, L. L. (1977). Rape: Power, anger and sexuality. American Journal of Psychiatry, 134, 1239–1243.PubMedGoogle Scholar
  31. Heim, N., and Hursch, C. J. (1979). Castration for sexual offenders: Treatment or punishment? A review and critique of recent European literature. Archives of Sexual Behavior, 8, 281–304.PubMedCrossRefGoogle Scholar
  32. Heller, C. G., Laidlaw, W. M., Harvey, H. I. T., and Nelson, W. O. (1958). Effects of progestational compounds on the reproductive processes of the human male. Annals of the New York Academy of Science, 71, 649–655.CrossRefGoogle Scholar
  33. Hsueh, A. J., Peck, E. J., and Clark, J. H. (1976). Control of uterine receptor levels by progesterone. Endocrinology, 98, 438–444.PubMedCrossRefGoogle Scholar
  34. Kreuz, L. E., and Rose, R. M. (1972). Assessment of aggressive behaviour and plasma testosterone in a young criminal population. Psychosomatic Medicine, 34, 321–332.PubMedGoogle Scholar
  35. Lan, N. C., and Katzenellenbogen, B. S. (1976). Temporal relationships between hormone receptor binding and biological responses in the uterus: Studies with short and long acting derivatives of estradiol. Endocrinology, 98, 220–227.PubMedCrossRefGoogle Scholar
  36. Langevin, R., Paitich, D., Hucker, S., Newman, S., Ramsay, G., Pope, S., Geller, G., and Anderson, C. (1979). The effect of assertiveness training, provera and sex of therapist in the treatment of genital exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry, 10, 275–282.CrossRefGoogle Scholar
  37. Laschet, U., and Laschet, L. (1971). Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychiatrie Neuropsychopharmakologic, 4, 99–104.CrossRefGoogle Scholar
  38. Laschet, U., and Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 6, 821–826.PubMedCrossRefGoogle Scholar
  39. Le Maire, L. (1956). Danish experiences regarding the castration of sexual offenders. Journal of Criminal Law, Criminology and Police Science, 47, 295–310.Google Scholar
  40. Liang, T., Tymoczko, J. L., Chan, K. M. B., Hung, H. C. and Liao, S. (1977). Androgen action: Receptors and rapid responses. In L. Martini and M. Motta (Eds.). Androgens and antiandrogens (pp. 77–89 ). New York: Raven Press.Google Scholar
  41. Lipsett, M. B., (1977). Regulation of androgen secretion. In L. Martini and M. Motta (Eds)., Androgens and antiandrogens (pp. 11–19 ). New York: Raven Press.Google Scholar
  42. Mainwaring, I. P. (1977). Modes of action of antiandrogens: A survey. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 151–161 ). New York: Raven Press.Google Scholar
  43. Malamuth, N. M., Check, J. V. P., and Briere, J. (1986). Sexual arousal in response to aggression: Ideological, aggressive and sexual correlates. Journal of Personal and Social Psychology, 50, 330–340.CrossRefGoogle Scholar
  44. Meyer, W. J., Walker, P. J., Emory, L. E., and Smith, E. R. (1985). Physical, metabolic and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. Fertility and Sterility, 43, 102–109.Google Scholar
  45. Meyer-Bahlburg, H. F. L., Nat, R., Boon, D. A., Sharma, M., and Edwards, J. A. (1974). Aggressiveness and testosterone measures in man. Psychosomatic Medicine, 36, 269–274.PubMedGoogle Scholar
  46. Money, J. (1968). Discussion of the hormonal inhibition of libido in male sex offenders. In R. Michael (Ed.), Endocrinology and human behaviour (p. 169 ). London: Oxford University Press.Google Scholar
  47. Money, J. (1970). Use of androgen depleting hormone in the treatment of male sex offenders. Journal of Sex Research, 6, 165–172.CrossRefGoogle Scholar
  48. Money, J. (1972). The therapeutic use of androgen-depleting hormone. International Psychiatry Clinics, 8, 165–174.Google Scholar
  49. Money, J., Wiedeking, C., Walker, P., Migeon, C., Meyer, W., and Borgaonkar, D. (1975). 47, XYY and 46, XY males with antisocial and/or sex-offending behaviour: Antiandrogen therapy plus counselling. Psychoneuroendocrinology, 1, 165–178.Google Scholar
  50. Money, J. M., Wiedeking, C., Walker, P. A., and Gain, D. (1976). Combined antiandrogen and counselling program for treatment of 46, XY and 47, XYY sex offenders. In E. Sachar (Ed.), Hormones, behavior and psychopathology (pp. 105–120 ). New York: Raven Press.Google Scholar
  51. Monti, P. M., Brown, W. A., and Corriveau, D. D. (1977). Testosterone and components of aggressive and sexual behavior in man. American Journal of Psychiatry, 134, 692–694.PubMedGoogle Scholar
  52. Mothes, C., Lehnert, J., Samimi, F., Sr Ufer, J. (1971). Schering symposium uber sexual deviationen und ihre medikamentose Behandlung. Life Sciences Monograph, 2, 65.Google Scholar
  53. Murray, M. A. F., Bancroft, J. H. H., Anderson, D. C., Tennent, T. G., and Carr, P. J. (1975). Endocrine changes in male sexual deviants after treatment with antiandrogens, oestrogens or tranquilizers. Journal of Endocrinology, 67, 179–188.PubMedCrossRefGoogle Scholar
  54. Naftolin, F., Ryan, K. J., and Petro, Z. (1972). Aromatization of androstenediol in the anterior hypothalamus of adult male and female rats. Endocrinology, 90, 295–298.PubMedCrossRefGoogle Scholar
  55. Neumann, F. (1977). Pharmacology and potential use of cyproterone acetate. Hormone and metabolic research, 9, 1–13.PubMedCrossRefGoogle Scholar
  56. Olweus, D., Mattsson, A., Schalling, D., and Low, H. (1980). Testosterone, aggression, physical and personality dimensions in normal adolescent males. Psychosomatic Medicine, 42, 253–269.PubMedGoogle Scholar
  57. Ortmann, J. (1980). The treatment of sexual offenders, castration and antihormone therapy. International Journal of Law and Psychiatry, 3, 443–451.PubMedCrossRefGoogle Scholar
  58. Ortmann, J. (1984a). How castration influences on relapsing into sexual criminality among Danish males. Unpublished manuscript.Google Scholar
  59. Ortmann, J. (1984b). How antihormone treatment with cyproterone acetate influences on relapsing into sexual criminality in male sexual offenders. Unpublished manuscript.Google Scholar
  60. Ott, F. and Hoffet, H. (1968). The Influence of Antiandrogens on Libido, Potency, and Testicular Function. Schweizerische Medizinische Wochenschrift, 98, 1812–1815.PubMedGoogle Scholar
  61. Persky, H., Smith, K. D., and Basu, G. K. (1971). Relation of psychologic measures of aggression and hostility to testosterone production in man. Psychosomatic Medicine, 40, 265–277.Google Scholar
  62. Rada, R. T. (1978). Classification of the rapist. In R. T. Rada (Ed.), Clinical aspects of the rapist (pp. 117–132 ). New York: Grune and Stratton.Google Scholar
  63. Rada, R. T., Laws, D. R., and Kellner, R. (1976). Plasma testosterone levels in the rapist. Psychosomatic Medicine, 38, 257–268.PubMedGoogle Scholar
  64. Scaramella, T. J., and Brown, W. A. (1978). Serum testosterone and aggressiveness in hockey players. Psychosomatic Medicine, 40, 262–265.PubMedGoogle Scholar
  65. Southren, A. L., Gordon, G. G., Vittek, J., and Altman, K. (1977). Effect of progestagens on androgen metabolism. In L. Martini and M. Motta (Eds.), Androgens and antiandrogens (pp. 263–279 ). New York: Raven Press.Google Scholar
  66. Sterkmans, P., and Geerts, F. (1966). Is benperidol (RF 504) the specific drug for the treatment of excessive and disinhibited sexual behaviour? Acta Neurologica Psychiatrica (Belgique), 66, 1030–1040.Google Scholar
  67. Stump, G. K. (1968). Treatment of sexual offenders in Herstedvester, Denmark: The rapists. Acta Psychiatrica Scandinavica (Suppl. 204 ), 5–61.Google Scholar
  68. Stump, G. K. (1972). Castration: The total treatment. In H. L. P. Resnik and M. E. Wolfgang (Eds.), Sexual behaviors: Social, clinical and legal aspects (pp. 361–382 ). Massachusetts: Little, Brown.Google Scholar
  69. Symmers, W. S. C. (1968). Carcinoma of the breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. British Medical Journal, 2, 3–85.CrossRefGoogle Scholar
  70. Tennent, G., Bancroft, J., and Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine and placebo. Archives of Sexual Behavior, 3, 261–271.PubMedCrossRefGoogle Scholar
  71. Walker, P. A., and Meyer, W. J. (1981). Medroxyprogesterone acetate treatment for paraphiliac sex offenders. In J. R. Hays, T. K. Roberts, and K. S. Solway (Eds.), Violence and the violent individual (pp. 353–373 ). New York: S.P. Medical and Scientific Books.Google Scholar
  72. Whittaker, L. H. (1959). Oestrogens and psychosexual disorders. Medical Journal of Australia, 2, 547–549.Google Scholar
  73. Wiedeking, C., Money, J., and Walker, P. A. (1979). Follow up of 11 XYY males with impulsive and/or sex-offending behavior. Psychological Medicine, 9, 287–292.PubMedCrossRefGoogle Scholar
  74. Wilson, J. D. and Foster, D. W. (1983). Introduction. In J. D. Wilson and D. W. Foster (Eds.), Textbook of endocrinology (pp 1–7 ). New York: Saunders.Google Scholar
  75. Wincze, W. P., Bansal, S., and Malamud, M. (1986). Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation and nocturnal penile tumescence in male sex offenders. Archives of Sexual Behavior, 15, 293–305.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • J. M. W. Bradford
    • 1
  1. 1.The Royal Ottawa Hospital and the University of OttawaOttawaCanada

Personalised recommendations